Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Sarit Schwartz
Introduction
Sarit Schwartz is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of cancer research through his innovative patent. His work focuses on the quantification of specific proteins in biological samples, which is crucial for cancer diagnostics and treatment.
Latest Patents
Sarit Schwartz holds a patent for "SRM/MRM assays for cancer." This patent provides methods for quantifying specific proteins directly in biological samples that have been fixed in formalin. The methods involve using SRM/MRM mass spectrometry to detect and quantify proteins such as CD3D, B7H3, B7-2, STAT1, GBP1, GPNMB, CD27, CD3E, and CD8. These proteins can be detected in various formalin-fixed biological samples, including tissues and cells treated with formaldehyde-containing agents.
Career Highlights
Sarit Schwartz is associated with Expression Pathology Incorporated, where he applies his expertise in protein quantification. His innovative approaches have the potential to enhance cancer diagnostics and improve patient outcomes. His work is recognized for its scientific rigor and practical applications in the medical field.
Collaborations
Sarit collaborates with talented professionals in his field, including Todd Hembrough and Fabiola Cecchi. Their combined expertise contributes to the advancement of cancer research and the development of effective diagnostic tools.
Conclusion
Sarit Schwartz's contributions to cancer research through his innovative patent demonstrate the importance of scientific advancements in healthcare. His work not only enhances our understanding of cancer but also paves the way for improved diagnostic methods.